RRSO |
Most effective form of ovarian cancer risk reduction |
Risks associated with the surgical procedure |
|
Associated with reduction in breast cancer risk, if performed prior to menopause |
Adverse effects of hormonal deprivation (sudden onset of menopausal symptoms, increased risk of osteoporosis, increased risk of metabolic syndrome) |
|
|
Residual breast, ovarian and peritoneal cancer risk |
|
|
Concern about adverse effects on sexuality |
|
|
Concern that HRT may increase breast cancer risk, and thus reverse the beneficial effects of the surgery on breast cancer risk |
Surveillance |
Noninvasive |
Multiple false positives |
|
May reduce cancer mortality |
Majority of detected cases are diagnosed at late stage |
|
|
Does not reduce risk of ovarian cancer |
|
|
Adherence issues |